DDX3X and pancreatic ductal adenocarcinoma: In a cohort of 106 pancreatic ductal adenocarcinomas (PDAC) [83], high CD112 and DDX3 (DEAD-box helicase 3 X-linked) expression levels were associated with poor prognosis and progression.